Replies to post #1521918 on BB's Stock Haven

[pick em low]

that's when they vote to dissolve company (XTNT) However after they decided to dissolve company (worth = .11 to .40 per share excluding the value of their intellectual property), the FDA approved a late stage clinical trial (see PR's) for their stent, so the co. looking into strategic alternatives. I can't see that no one would buy them or their technology portfolio, it's just a matter of what it's worth